The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma

Homer A. Macapinlac

doi:10.1016/j.mibio.2004.04.002

The utility of 2-deoxy-2-[¹⁸F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma

Homer A. Macapinlac

Nuclear Medicine

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

The purpose of this article is to review the clinical utility of FDG and FDG PET/CT imaging in lymphoma and melanoma. A review of the important articles supporting the use of FDG PET imaging in the staging, restaging, and monitoring of response to therapy in lymphoma and melanoma is provided. The intent is to give the nuclear medicine physician and or radiologist the perspective of what may be important clinically to make FDG PET imaging an integral part of the workup of lymphoma and melanoma patients. Specific clinical scenarios and uptake patterns that are unique for lymphoma and melanoma are discussed to ensure relevant and proper interpretation of the FDG PET scans. FDG PET scanning in summary is a useful imaging modality in the staging, restaging, and response evaluation of patients with lymphoma and melanoma.

Original language	English (US)
Pages (from-to)	200-207
Number of pages	8
Journal	Molecular Imaging and Biology
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/j.mibio.2004.04.002
State	Published - 2004

Keywords

FDG
Lymphoma
Melanoma
PET

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1016/j.mibio.2004.04.002

Cite this

@article{4044f15320e04c89bd2d395c03cb5977,

title = "The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma",

abstract = "The purpose of this article is to review the clinical utility of FDG and FDG PET/CT imaging in lymphoma and melanoma. A review of the important articles supporting the use of FDG PET imaging in the staging, restaging, and monitoring of response to therapy in lymphoma and melanoma is provided. The intent is to give the nuclear medicine physician and or radiologist the perspective of what may be important clinically to make FDG PET imaging an integral part of the workup of lymphoma and melanoma patients. Specific clinical scenarios and uptake patterns that are unique for lymphoma and melanoma are discussed to ensure relevant and proper interpretation of the FDG PET scans. FDG PET scanning in summary is a useful imaging modality in the staging, restaging, and response evaluation of patients with lymphoma and melanoma.",

keywords = "FDG, Lymphoma, Melanoma, PET",

author = "Macapinlac, {Homer A.}",

year = "2004",

doi = "10.1016/j.mibio.2004.04.002",

language = "English (US)",

volume = "6",

pages = "200--207",

journal = "Molecular Imaging and Biology",

issn = "1536-1632",

publisher = "Springer New York",

number = "4",

}

TY - JOUR

T1 - The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma

AU - Macapinlac, Homer A.

PY - 2004

Y1 - 2004

N2 - The purpose of this article is to review the clinical utility of FDG and FDG PET/CT imaging in lymphoma and melanoma. A review of the important articles supporting the use of FDG PET imaging in the staging, restaging, and monitoring of response to therapy in lymphoma and melanoma is provided. The intent is to give the nuclear medicine physician and or radiologist the perspective of what may be important clinically to make FDG PET imaging an integral part of the workup of lymphoma and melanoma patients. Specific clinical scenarios and uptake patterns that are unique for lymphoma and melanoma are discussed to ensure relevant and proper interpretation of the FDG PET scans. FDG PET scanning in summary is a useful imaging modality in the staging, restaging, and response evaluation of patients with lymphoma and melanoma.

AB - The purpose of this article is to review the clinical utility of FDG and FDG PET/CT imaging in lymphoma and melanoma. A review of the important articles supporting the use of FDG PET imaging in the staging, restaging, and monitoring of response to therapy in lymphoma and melanoma is provided. The intent is to give the nuclear medicine physician and or radiologist the perspective of what may be important clinically to make FDG PET imaging an integral part of the workup of lymphoma and melanoma patients. Specific clinical scenarios and uptake patterns that are unique for lymphoma and melanoma are discussed to ensure relevant and proper interpretation of the FDG PET scans. FDG PET scanning in summary is a useful imaging modality in the staging, restaging, and response evaluation of patients with lymphoma and melanoma.

KW - FDG

KW - Lymphoma

KW - Melanoma

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=3543116692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543116692&partnerID=8YFLogxK

U2 - 10.1016/j.mibio.2004.04.002

DO - 10.1016/j.mibio.2004.04.002

M3 - Article

C2 - 15262235

AN - SCOPUS:3543116692

SN - 1536-1632

VL - 6

SP - 200

EP - 207

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

IS - 4

ER -